Patients of open-angle glaucoma, secondary glaucoma, and preoperatively acute angle-closure glaucoma are no longer required to suffer from surgery delays due to high intraocular pressure(IOP). Diamox, X-GEN Pharmaceuticals has devised a new adjunctive treatment for lowering IOP. Full article »
Today Glaucoma has become the second leading cause of blindness worldwide, affecting affecting more than 65 million people globally. Experts say that the major reason behind this is the negligence of the people towards eye symptoms. This eye disease symptoms if taken proper care at right time can stop vision loss that is caused due to glaucoma.